Chemical Compound

(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[3-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-oxopropyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid

CAS Registry Number 122063-01-8
(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[3-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-oxopropyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid 结构式
Primary record

(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[3-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-oxopropyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid

库存
5,900 克
纯度
98.5 %
CAS
122063-01-8

化合物标识与属性

CAS
122063-01-8
PubChem CID
9987795
SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CCNC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N
Canonical SMILES
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CCNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(N)=O

名称与同义词

  • [bAla8]-Neurokinin A(4-10)
  • 122063-01-8
  • Bala-nka (4-10)
  • [betaAla8]NKA(4-10)
  • C35H56N8O10S
  • (Betaala(8))nka(4-10)
  • MEN 10210
  • orb1679865
  • CHEMBL1875296
  • [betaAla8]neurokinin A(4-10)
  • CKNPSJOMUQBPLA-WTWMNNMUSA-N
  • MFCD00143686
  • [beta-Ala8]neurokinin A(4-10)
  • HY-P1031
  • [|_-Ala8]Neurokinin A(4-10)
  • 8-beta-Ala-neurokinin A (4-10)
  • (b-Ala8)-Neurokinin A (4-10)
  • Asp-Ser-Phe-Val-beta-Ala-Leu-Met-NH2
  • neurokinin A (4-10), beta-Ala(8)-
  • ZINC95543647
  • AKOS024456720
  • C35-H56-N8-O10-S
  • CID9987795
  • CS-7598
  • NCGC00167336-01
  • [|A-Ala8]-Neurokinin A Fragment 4-10
  • AS-80269
  • DA-59741
  • J260.382I
  • Neurokinin A (4-10), beta-alanine(8)-
  • H-ASP-SER-PHE-VAL-BETA-ALA-LEU-MET-NH2
  • L-Methioninamide, L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-valyl-beta-alanyl-L-leucyl-
  • (3S)-3-AMINO-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-[(2-{[(1S)-1-{[(1S)-1-CARBAMOYL-3-(METHYLSULFANYL)PROPYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}ETHYL)CARBAMOYL]-2-METHYLPROPYL]CARBAMOYL}-2-PHENYLETHYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}PROPANOIC ACID
  • (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[3-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-oxopropyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
  • [beta-Ala8]-Neurokinin A Fragment 4-10, >=97% (HPLC), powder
  • L-Methioninamide, L-|A-aspartyl-L-seryl-L-phenylalanyl-L-valyl-|A-alanyl-L-leucyl-
  • L-Methioninamide,l-a-aspartyl-L-seryl-L-phenylalanyl-L-valyl-b-alanyl-L-leucyl-
  • (3S)-3-amino-4-[[(1S)-2-[[(1S)-1-benzyl-2-[[(1S)-1-[[3-[[(1S)-1-[[(1S)-1-carbamoyl-3-methylsulfanyl-propyl]carbamoyl]-3-methyl-butyl]amino]-3-oxo-propyl]carbamoyl]-2-methyl-propyl]amino]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-4-oxo-butanoic acid